Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
Antimalarial drugs have usually been first deployed in areas of malaria endemicity at doses which were too low, particularly for high-risk groups such as young children and pregnant women. This may accelerate the emergence and spread of resistance, thereby shortening the useful life of the drug, but...
Autore principale: | White, N |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2013
|
Documenti analoghi
Documenti analoghi
-
Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
di: Banda, CG, et al.
Pubblicazione: (2024) -
Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
di: Kloprogge, F
Pubblicazione: (2013) -
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
di: Tarning, J, et al.
Pubblicazione: (2014) -
Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
di: Tarning, J, et al.
Pubblicazione: (2014) -
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
di: White, N
Pubblicazione: (1997)